Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India
- 21 June 2018
- journal article
- research article
- Published by International Union Against Tuberculosis and Lung Disease in Public Health Action
- Vol. 8 (2), 59-65
- https://doi.org/10.5588/pha.18.0003
Abstract
Setting: Gujarat, a state in west India. Background: Although treatment initiation has been improving among patients diagnosed with multidrug-resistant tuberculosis (MDR-TB) in programme settings, it has still not reached 100%. Objectives: To determine pre-treatment attrition (not initiated on treatment within 6 months of diagnosis), delay in treatment initiation (>7 days from diagnosis) and associated factors among MDR-TB patients diagnosed in 2014 in five selected districts served by two genotypic drug susceptibility testing (DST) facilities and a drug-resistant TB centre in Gujarat. Design: This was a retrospective cohort study involving record review. Results: Among 257 MDR-TB patients, pre-treatment attrition was seen in 20 (8%, 95% CI 5-12). Patients with 'follow-up sputum-positive' as their DST criterion and sputum smear microscopy status 'unknown' at the time of referral for DST were less likely to be initiated on treatment. The median delay to treatment initiation was 8 days (interquartile range 6-13). Patients referred for DST from medical colleges were more likely to face delays in treatment initiation. Conclusion: The Gujarat TB programme is performing well in initiating laboratory-confirmed MDR-TB patients on treatment. However, there is further scope for reducing delay.This publication has 27 references indexed in Scilit:
- Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, IndiaJournal of Epidemiology and Global Health, 2017
- Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, ChinaPLOS ONE, 2017
- MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathwayPublic Health Action, 2016
- The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, RussiaPLOS ONE, 2016
- The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in BangladeshPLOS ONE, 2015
- Management of previously treated tuberculosis patients in Kalutara district, Sri Lanka: how are we faring?Public Health Action, 2014
- Genetic polymorphisms of CYP2E1 and GSTM1 loci and susceptibility to anti-tuberculosis drug-induced hepatotoxicityThe International Journal of Tuberculosis and Lung Disease, 2014
- Are We Doing Enough to Stem the Tide of Acquired MDR-TB in Countries with High TB Burden? Results of a Mixed Method Study in Chongqing, ChinaPLOS ONE, 2014
- Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011The International Journal of Tuberculosis and Lung Disease, 2013
- Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi.2004